青年体检人群血脂异常情况及危险因素

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1244 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the status and risk factors of dyslipidemia among young adults of Wenzhou reported by the health examination in order to provide intervention measures. Methods: The individuals aged 18-45 years were recruited through multi-stage random sampling from the Medical Examination Center of the 2nd Affiliated Hospital of Wenzhou Medical University. The survey included questionnaire, physical examination and laboratory detections of triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C). Results: A total of 8 497 young adults were investigated, including 4 295 males and 4 202 females. The prevalence of dyslipidemia was 34.11%, with 51% in male and 16.7% in female; The average age was (34.07±7.11) years old in male and (34.52±7.08) years old in female. The level of serum TG, TC, HDL-C and LDL-C was (1.69±0.07) mmol/L, (4.66±0.18) mmol/L, (1.21±0.05) mmol/L, (2.69±0.11) mmol/L. Logistic regression analysis showed that the risk factors included age (OR=1.032), smoking (OR=2.016), drinking (OR=1.334), overweight (OR=1.228), occupation (OR=1.058). Conclusion: The prevalence of dyslipidemia among young adults in Wenzhou is high. It suggests that targeted prevention and control measures are needed to lower the prevalence of dyslipidemia.

Key words： dyslipidemia young adults risk factors Wenzhou

Received: 13 December 2017

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	CHEN Keyang
	HU Beilei
	CHEN Songfang
	JIANG Minghua
	CHEN Ke
	WANG Xiaotong

URL:

https://xb.wmu.edu.cn/EN/ OR https://xb.wmu.edu.cn/EN/Y2018/V48/I4/275

[1] GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390(10100): 1151-1210.
[2] WILLIAMS L S, GARG B P, COHEN M, et al. Subtypes of ischemic stroke in children and young adults[J]. Neurology, 1997, 49(6): 1541-1550.
[3] SMAJLOVIC D. Strokes in young adults: epidemiology and prevention[J]. Vasc Health Risk Manag, 2015, 11: 157-164.
[4] ANDERSSON C, VASAN R S. Epidemiology of cardiovascular disease in young individuals[J]. Nat Rev Cardiol, 2018, 15(4): 230-240.
[5] OLAMOYEGUN M A, AKINLADE A T, FAWALE M B,
et al. Dyslipidaemia as a risk factor in the occurrence of stroke in Nigeria: prevalence and patterns[J]. Pan Afr Med J, 2016, 25: 72.
[6] 诸骏仁, 高润霖, 赵水平, 等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016(10): 937-953.
[7] 邵永强, 李江峰, 樊丽辉, 等. 2011年温州市心脑血管疾病死亡分布分析[J]. 疾病监测, 2013(6): 481-483.
[8] 王贞, 韩钊, 邵蓓, 等. 温州地区中青年脑卒中各年龄段特点及危险因素分析[J]. 心脑血管病防治, 2009(4): 288-290.
[9] SINGHAL A B, BILLER J, ELKIND M S, et al. Recognition and management of stroke in young adults and adoles-cents[J]. Neurology, 2013, 81(12): 1089-1097.
[10] 丁文清, 董虹孛, 米杰. 中国儿童青少年血脂异常流行现状Meta分析[J]. 中华流行病学杂志, 2015, 36(1): 71-77.
[11] 张新卫, 叶真, 周丹, 等. 浙江省成年居民血脂异常患病率及其分布特征的现况分析[J]. 疾病监测, 2012(5): 395-399.
[12] 张坚, 满青青, 王春荣, 等. 中国18岁及以上人群血脂水平及分布特征[J]. 中华预防医学杂志, 2005(5): 8-11.
[13] BAYRAM F, KOCER D, GUNDOGAN K, et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults [J]. J Clin Lipidol, 2014, 8(2): 206-216.
[14] BENJAMIN E J, BLAHA M J, CHIUVE S E, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association[J]. Circulation, 2017, 135(10): e146-e603.
[15] REDDY KILIM S, CHANDALA S R. A comparative study of lipid profile and oestradiol in pre- and post-menopausal women[J]. J Clin Diagn Res, 2013, 7(8): 1596-1598.
[16] DJINDJIC N, JOVANOVIC J, DJINDJIC B, et al. Work stress related lipid disorders and arterial hypertension in professional drivers-a cross-sectional study[J]. Vojnosanit Pregl, 2013, 70(6): 561-568.
[17] KIVIMAKI M, KAWACHI I. Work stress as a risk factor for cardiovascular disease[J]. Curr Cardiol Rep, 2015, 17(9): 630.
[18] KLOP B, ELTE J W, CABEZAS M C. Dyslipidemia in obesity: mechanisms and potential targets[J]. Nutrients, 2013, 5 (4): 1218-1240.
[19] TOTH P P, PATTI A M, NIKOLIC D, et al. Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study[J]. Front Pharmacol, 2015, 6: 299.